Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC18530 structure
    GC18530CAY10616
    CAS: 586410-08-4

    Pro-apoptotic analog of resveratrol

  • GC18533 structure
    GC18533ZLDI-8
    CAS: 667880-38-8
    纯度: >98.50%

    ZLDI-8 是一种 Notch 激活/切割酶 ADAM-17 抑制剂,可抑制 Notch 蛋白的切割。 ZLDI-8 降低促存活/抗凋亡和上皮间质转化 (EMT) 相关蛋白的表达。 ZLDI-8 还是一种竞争性且不可逆的酪氨酸磷酸酶 (Lyp) 抑制剂,IC50 为 31.6 μM,Ki 为 26.22 μM。 ZLDI-8 抑制 MHCC97-H 细胞的生长,IC50 为 5.32 μM。

  • GC18536 structure
    GC18536Chartreusin
    CAS: 6377-18-0

    An antibiotic with diverse biological activites

  • GC18547 structure
    GC18547Psoromic Acid
    CAS: 7299-11-8

    An inhibitor of Rab geranylgeranyl transferase and P. falciparum FAS II enzymes

  • GC18556 structure
    GC18556Degarelix (acetate)
    CAS: 934016-19-0

    A synthetic GNRHR antagonist

  • GC18566 structure
    GC18566AZD 3147
    CAS: 1101810-02-9

    A dual mTORC1/mTORC2 inhibitor

  • GC18572 structure
    GC18572Concanavalin A
    CAS: 11028-71-0
    纯度: >98.00% / 不显示

    Concanavalin A属于concanamycin,这是一种从异色链霉菌中分离出来的大环内酯类抗生素,是液泡质子- atp酶(v-[H[+]] atp酶)的高活性和选择性抑制剂。

  • GC18604 structure
    GC18604Calcein Blue AM
    CAS: 168482-84-6
    纯度: >98.00%

    A fluorogenic dye

  • GC18611 structure
    GC18611Fusicoccin
    CAS: 20108-30-9
    纯度: >90.00%

    A phytotoxin

  • GC18624 structure
    GC18624Roslin-2
    CAS: 29574-21-8

    A reactivator of p53

  • GC18641 structure
    GC18641Ferutinin
    CAS: 41743-44-6
    纯度: >98.00%

    An ERα agonist

  • GC18652 structure
    GC18652FQI 1
    CAS: 599151-35-6

    An inhibitor of Late SV40 Factor

  • GC18677 structure
    GC18677YMU1
    CAS: 902589-96-2

    A thymidylate kinase inhibitor

  • GC18701 structure
    GC18701Hellebrin
    CAS: 13289-18-4
    纯度: >99.00%

    An Na + /K + -ATPase inhibitor

  • GC18727 structure
    GC18727O-methyl Sterigmatocystin
    CAS: 17878-69-2

    An aflatoxin precursor

  • GC18734 structure
    GC18734JS-K
    CAS: 205432-12-8
    纯度: >95.00%

    A nitric oxide donor

  • GC18749 structure
    GC18749(+)-Rugulosin
    CAS: 23537-16-8
    纯度: >98.00%

    A mycotoxin

  • GC18751 structure
    GC18751Reticulol
    CAS: 26246-41-3

    A cAMP phosphodiesterase and DNA topoisomerase I inhibitor

  • GC18769 structure
    GC18769MST-312
    CAS: 368449-04-1
    纯度: >98.00%

    MST-312是一种强效的端粒酶抑制剂,IC 50 值为0.67μM。

  • GC18787 structure
    GC18787(±)-Dunnione
    CAS: 521-49-3

    A naphthoquinone with diverse biological activities

  • GC18796 structure
    GC18796Herbicidin A
    CAS: 55353-31-6
    纯度: >98.00%

    An adenine nucleoside antibiotic with herbicidal activity

  • GC18832 structure
    GC18832Conglobatin
    CAS: 72263-05-9

    An Hsp90 inhibitor

  • GC18847 structure
    GC18847RSM-932A
    CAS: 850807-63-5
    纯度: >98.00%

    RSM-932A 是一种 ChoKα 抑制剂,对多种肿瘤来源的细胞系具有有效的体外抗增殖活性,对小鼠的人异种移植物具有体内抗肿瘤活性。

  • GC18852 structure
    GC18852S14161
    CAS: 883046-50-2

    An inhibitor of cyclin D transactivation